Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke

BACKGROUND: Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic properties, has been shown to promote therapeutic benefits in experimental stroke. However, equally compelling evidence demonstrates that the drug exerts variable and even detrimental effects in many...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsukawa, Noriyuki, Yasuhara, Takao, Hara, Koichi, Xu, Lin, Maki, Mina, Yu, Guolong, Kaneko, Yuji, Ojika, Kosei, Hess, David C, Borlongan, Cesar V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762982/
https://www.ncbi.nlm.nih.gov/pubmed/19807907
http://dx.doi.org/10.1186/1471-2202-10-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762982/
https://www.ncbi.nlm.nih.gov/pubmed/19807907
http://dx.doi.org/10.1186/1471-2202-10-126

Ejemplares similares